AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Prescient Therapeutics Extends SPP Timeline | ASX 300 Biotech Eyes PTX-100 Progress
July 15, 2025 04:09 PM AEST| By Team Kalkine MediaHighlights,Prescient Therapeutics extends Share Purchase Plan deadline,Funds allocated to advance Phase 2 trial for oncology candidate PTX-100,Broader pipeline includes cell therapy enhancements and modular CAR-T platform,Prescient Therapeutics Ltd (...
Compumedics (ASX:CMP) Marks Major Turnaround with Robust Revenue Growth and Strategic Vision
July 15, 2025 11:39 AM AEST| By Team Kalkine MediaHighlights,Compumedics records robust growth across Sleep & Neurology segments,SaaS platforms show expanding global traction,Strategic focus aligned with,high-margin,recurring revenue model,Compumedics (ASX:CMP), a notable medical technology company,...
Compumedics Signals Strategic Growth Shift with Record Results: Momentum Builds Across SaaS and Sleep Diagnostics
July 15, 2025 10:12 AM AEST| By Team Kalkine MediaHighlights,Compumedics shifts into a new growth phase with innovation-led momentum,Sleep diagnostics and SaaS platforms,emerge,as key revenue drivers,Expansion in global neurotech markets supports long-term growth strategy,Compumedics (ASX:CMP) is st...
Imugene (ASX:IMU) Progresses Azer-cel Trial with Promising Data Amid ASX200 Landscape
July 14, 2025 11:43 AM AEST| By Team Kalkine MediaHighlights,Positive data drives Imugene’s expansion of trial scope,Azer-cel shows strong promise in relapsed lymphoma cases,Regulatory progress signals broader therapeutic potential,Imugene (ASX:IMU), a clinical-stage immuno-oncology company, has rep...
Imugene’s Azer-cel Advances in Phase 1b Trial for DLBCL Amidst Strong Momentum | ASX200 Share Price Insight
July 14, 2025 10:42 AM AEST| By Team Kalkine MediaHighlights,Azer-cel shows encouraging responses in advanced DLBCL trial,FDA meeting planned for next steps in pivotal study,Trial expansion to include broader B-cell lymphoma subtypes,Imugene Ltd (ASX:IMU) has released positive data from its Phase 1b...
Ramsay Health Care’s Momentum vs Fundamentals: ASX 100 Share Price Rally in Focus
July 11, 2025 05:44 PM AEST| By Team Kalkine MediaHighlights,Ramsay Health Care shows recent share price strength,Financial indicators raise key concerns,ROE reveals efficiency pressure,Ramsay Health Care (ASX:RHC), a prominent name in the healthcare sector, has experienced a noticeable upward movem...
Is Sonic Healthcare (ASX:SHL) Losing Its Momentum in the ASX 100 Growth Race?
July 11, 2025 05:22 PM AEST| By Team Kalkine MediaHighlights,Sonic Healthcare’s ROCE trend shows limited improvement,Capital deployment not delivering stronger efficiency gains,Growth trajectory appears to be slowing despite expansion efforts,Sonic Healthcare (ASX:SHL) has built a reputation as one...
Orthocell Hits US Breakthrough, Boosts ASX 200 Biotech Momentum
July 11, 2025 04:01 PM AEST| By Team Kalkine MediaHighlights,Orthocell Ltd confirms first commercial sales of Remplir™ in the US,FDA clearance achieved earlier this year followed by initial surgical usage,Company focused on expanding its US footprint through strategic distribution,Biotech company Or...
Telix Pharmaceuticals (ASX:TLX) Eyes US Milestone as Zircaix Decision Nears | ASX 200
July 11, 2025 03:48 PM AEST| By Team Kalkine MediaHighlights,Telix Pharmaceuticals (ASX:TLX) awaits US FDA decision on Zircaix radiopharmaceutical,Zircaix aims to be the first imaging agent labeled for renal mass detection,Market size estimates highlight strong near-term potential for commercialisat...
ASX Top 300 Healthcare Focus: Can These Two Biotech Shares Rebound Strongly?
July 10, 2025 05:40 PM AEST| By Team Kalkine MediaHighlights,Clinical progress sparks attention for key biotech firms,U.S. regulatory path sets milestone for one heart device innovator,Radiopharmaceutical developments may unlock commercial,Two healthcare companies on the ASX have continued to genera...
Mach7 Technologies (ASX:M7T) Updates FY25 Outlook with Strategic Moves and Share Buyback
July 10, 2025 05:01 PM AEST| By Team Kalkine MediaHighlights,FY25 revenue guidance reaffirmed amid recurring revenue growth,Ongoing share buyback signals confidence in long-term value,Debt-free position with strong cash flow forecast for FY25,Mach7 Technologies (ASX:M7T),has shared its latest FY25 b...
Orthocell (ASX:OCC) Enters US Market with First Remplir™ Sales — Momentum Outside ASX 200 Share Price Radar
July 10, 2025 04:47 PM AEST| By Team Kalkine MediaHighlights,Orthocell registers first US revenue for Remplir™,Strategic groundwork supports US market entry,Strong cash position to support international expansion,Orthocell (ASX:OCC) has marked a pivotal moment in its commercial journey with the reco...
Orthocell (ASX:OCC) Expands into US Market with First Remplir™ | All Ordinaries
July 10, 2025 04:45 PM AEST| By Team Kalkine MediaHighlights,Orthocell secures initial revenue from Remplir™ following regulatory clearance in the US,First surgical procedures performed in Ohio and Florida via ambulatory surgery centres,Company advances logistics and commercial scaling with support...
ASX 300 Penny Stock Radar: Clarity Pharmaceuticals Gains Spotlight
July 10, 2025 04:35 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals maintains development focus in radiopharmaceuticals,Commercial manufacturing agreement in the US strengthens future production plans,ASX 300 company continues clinical trial momentum with multiple programs underway,...
Race Oncology Expands Global Clinical Reach with RC220 Trial Progress
July 10, 2025 03:56 PM AEST| By Team Kalkine MediaHighlights,RC220 Phase 1 trial approved at two Hong Kong hospitals,Expansion supports faster recruitment and regional relevance,Broadening cardio-oncology footprint with international sites,Race Oncology (ASX:RAC) has announced key regulatory progres...
Orthocell (ASX:OCC) Gains Momentum in the US Market | Allords Biotech Update
July 10, 2025 03:37 PM AEST| By Team Kalkine MediaHighlights,Orthocell (OCC) marks first US revenue milestone,FDA-cleared Remplir device used in US surgical procedures,Commercial progress reported following regulatory approval,The global biotech landscape is always evolving, and for Orthocell (ASX:O...
ASX 100 Healthcare Stock ResMed (ASX:RMD) Eyes Growth Through Innovation and Global Reach
July 10, 2025 03:28 PM AEST| By Team Kalkine MediaHighlights,ResMed (RMD) operates in over 140 countries,Focuses on CPAP therapy and SaaS for out-of-hospital care,Listed on both NYSE and ASX, with US reporting standards,ResMed (ASX:RMD), a global player in the medical equipment and digital health sp...
Orthocell (ASX:OCC) Enters US Market with Remplir™: A New Chapter for Nerve Repair and ASX 200 Share Price Watch
July 10, 2025 10:42 AM AEST| By Team Kalkine MediaHighlights,Orthocell,records first US revenue for,Remplir,™,Surgeries in Ohio and Florida mark commercial entry,Positioned for broader rollout in 2025,Orthocell (ASX:OCC), a regenerative medicine company, has officially marked its entry into the US m...
Biome Australia's Record-Breaking FY25: Revenue Surges Amid Growing Demand
July 09, 2025 05:16 PM AEST| By Team Kalkine MediaHighlights,Biome Australia reports record FY25 revenue milestone,Quarterly and monthly sales performance at all-time highs,Strong momentum driven by consistent demand for health products,Biome Australia (ASX:BIO) has released a notable update to the...
Island Pharmaceuticals Fast-Tracks Galidesivir Acquisition to Advance Anti-Viral Pipeline
July 09, 2025 04:40 PM AEST| By Team Kalkine MediaHighlights,Island Pharmaceuticals accelerates galidesivir program acquisition,Strategic focus on Marburg virus treatment development,Priority review voucher offers future regulatory advantage,Island Pharmaceuticals (ASX:ILA),has announced the acceler...
Advertise your brand on Kalkine Media